LDOS - Leidos Holdings, Inc. Stock Analysis | Stock Taper
Logo
Leidos Holdings, Inc.

LDOS

Leidos Holdings, Inc. NYSE
$127.80 -2.88% (-3.79)

Market Cap $16.08 B
52w High $205.77
52w Low $121.20
Dividend Yield 0.87%
Frequency Quarterly
P/E 11.68
Volume 2.60M
Outstanding Shares 125.79M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q1-2026 $4.4B $253M $328M 7.45% $2.6 $532M
Q4-2025 $4.21B $201.94M $335M 7.96% $2.53 $556M
Q3-2025 $4.47B $286M $367M 8.21% $2.87 $609M
Q2-2025 $4.25B $211M $391M 9.19% $3.03 $645M
Q1-2025 $4.25B $227M $363M 8.55% $2.79 $596M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q1-2026 $457M $15.39B $10.32B $5.01B
Q4-2025 $1.2B $13.49B $8.53B $4.92B
Q3-2025 $974M $13.54B $8.59B $4.91B
Q2-2025 $930M $13.55B $8.84B $4.66B
Q1-2025 $842M $13.2B $8.89B $4.26B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2026 $335M $301M $-2.36B $1.39B $-666M $270M
Q4-2025 $327M $495M $-49M $-341M $107M $452M
Q3-2025 $367M $711M $-36M $-595M $-46M $680M
Q2-2025 $393M $486M $-314M $-83M $96M $457M
Q1-2025 $365M $58M $-22M $-110M $-160M $36M

Revenue by Products

Product Q1-2025Q2-2025Q4-2025Q1-2026
Health Segment
Health Segment
$0 $0 $0 $1.19Bn
Civil Segment
Civil Segment
$1.29Bn $1.27Bn $2.50Bn $0
Defense Solution Segment
Defense Solution Segment
$510.00M $540.00M $1.13Bn $0
National Security Solutions
National Security Solutions
$2.43Bn $2.42Bn $5.02Bn $0

Revenue by Geography

Region Q1-2025Q2-2025Q4-2025Q1-2026
NonUS
NonUS
$350.00M $340.00M $720.00M $360.00M
UNITED STATES
UNITED STATES
$3.88Bn $0 $0 $0

Q1 2026 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Leidos Holdings, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Across the financials and strategy, Leidos shows several notable strengths: steady revenue growth, a pronounced step-up in profitability and margins, strong and rising free cash flow, and a transformed balance sheet with much lower leverage and better liquidity. Strategically, it benefits from entrenched relationships with U.S. government agencies, a large and visible contract backlog, and differentiated capabilities in mission AI, cyber, and advanced systems. These elements together create a business with solid earnings power and good visibility into near-term demand.

! Risks

Key risks include high exposure to U.S. federal spending priorities, particularly in defense and intelligence, and dependence on winning and retaining large contracts in highly competitive procurements. The balance sheet’s heavy goodwill and intangibles reflect an acquisition-driven history and carry some impairment risk. The apparent lack of clearly reported R&D spending contrasts with the innovation narrative, making long-term reinvestment levels harder to gauge. Finally, aggressive capital returns via buybacks, while supported by current cash flow, could reduce flexibility if conditions or opportunities change abruptly.

Outlook

Based on the recent trends, the outlook appears cautiously favorable: the company enters the coming years with stronger margins, ample free cash flow, reduced debt, and a robust pipeline of contracted work in structurally important areas like cyber, AI, space, and secure infrastructure. However, future performance will depend on how government budgets evolve, how effectively Leidos continues to innovate and integrate acquisitions, and whether it can balance shareholder distributions with the need to invest for long-term technological leadership. This assessment is descriptive, not a recommendation, and actual outcomes could differ if market, policy, or competitive conditions shift materially.